"Hartford HealthCare's Cancer Institute, backed by an alliance with the renowned Memorial Sloan Kettering Cancer Center, provides innovative care close to home."

During the past decade, Hartford Healthcare Cancer Institute @ Hartford Hospital conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hartford Healthcare Cancer Institute @ Hartford Hospital" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Hartford HealthCare" with 2 trials as a collaborator, "Hartford Hospital" with 2 trials as a collaborator, "Miami Cancer Institute" with 2 trials as a collaborator and "3M" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Hartford Healthcare Cancer Institute @ Hartford Hospital" are "Breast Cancer" (4 trials), "Acute Leukemia" (1 trials), "Advanced Pancreatic Ductal Adenocarcinoma" (1 trials), "Bladder Cancer" (1 trials) and "Brain Tumor" (1 trials). Many other conditions were trialed in "Hartford Healthcare Cancer Institute @ Hartford Hospital" in a lesser frequency.

Most popular intervention types in "Hartford Healthcare Cancer Institute @ Hartford Hospital" are "Drug" (9 trials), "Behavioral" (5 trials), "Other" (4 trials), "Device" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Gemcitabine" (3 trials), "Assessments" (1 trials), "Atezolizumab" (1 trials), "Blood draw" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hartford Healthcare Cancer Institute @ Hartford Hospital" are 9 trials for "Female" genders and 8 trials for "All" genders.

Currently, there are NaN active trials in "Hartford Healthcare Cancer Institute @ Hartford Hospital". undefined are not yet recruiting, 3 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hartford Healthcare Cancer Institute @ Hartford Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hartford Healthcare Cancer Institute @ Hartford Hospital, 2 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".